Skip to main content

Table 2 Antifungal susceptibility to caspofungin according to CLSI M27-A3 and micafungin according to CLSI M27-S4

From: New echinocandin susceptibility patterns for nosocomial Candida albicans in Bogotá, Colombia, in ten tertiary care centres: an observational study

Strain

MIC CSF

MIC MCF

SC5314

≤0.25 μg/mL (S)

≤0.25 μg/mL (S)

GV475

≥1 μg/mL (R)

≤0.25 μg/mL (S)

GV78

0.5 μg/mL (I)

≤0.25 μg/mL (S)

GV527

2 μg/mL (R)

≤0.25 μg/mL (S)

GV242

≥1 μg/mL (R)

≤0.25 μg/mL (S)

GV147

≥1 μg/mL (R)

≤0.25 μg/mL (S)

GV608

≥1 μg/mL (R)

0.5 μg/mL (R)

  1. Note: MIC: minimal inhibitory concentration, CSF: caspofungin, MCF: micafungin, S: susceptible, I: intermediate, R: resistant.
  2. The isolate resistant to both caspofungin and micafungin is shown in bold.